DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
PARSATUZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Non-Small-Cell Lung
Epidermal growth factor-like protein 7 inhibitor
PARSATUZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
435M4HCP2M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACOZIBOROLE
2
Small molecule
Investigational
Unknown
Unknown
Trypanosomiasis, African
Cleavage and polyadenylation specificity factor subunit inhibitor
ACOZIBOROLE
×
Maximum Phase:
2
First Approval:
None
UNII:
2IOR2OO3GW
Molecule Type:
Small molecule
Molecular Formula:
C17H14BF4NO3
Molecular Weight:
367.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
L-DOS47
2
Unknown
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms; Adenocarcinoma of Lung
Unknown
L-DOS47
×
Maximum Phase:
2
First Approval:
None
UNII:
95E1ZQM329
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
7-METHYLXANTHINE
2
Small molecule
Investigational
Unknown
Unknown
Myopia
Unknown
7-METHYLXANTHINE
×
Maximum Phase:
2
First Approval:
None
UNII:
E9M81NJM6G
Molecule Type:
Small molecule
Molecular Formula:
C6H6N4O2
Molecular Weight:
166.14
AlogP:
-0.23
PSA:
84.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
ASUNERCEPT
2
Protein
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Glioblastoma; Severe Acute Respiratory Syndrome
Tumor necrosis factor ligand superfamily member 6 binding agent
ASUNERCEPT
×
Maximum Phase:
2
First Approval:
None
UNII:
F333OQQ9UV
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DELPAZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis, Pulmonary
Bacterial 70S ribosome inhibitor
DELPAZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
43EP6XV33E
Molecule Type:
Small molecule
Molecular Formula:
C14H17FN4O3
Molecular Weight:
308.31
AlogP:
0.84
PSA:
68.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
BMX-010
2
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 1; Acne Vulgaris; Dermatitis, Atopic; Psoriasis; Rosacea
Unknown
BMX-010
×
Maximum Phase:
2
First Approval:
None
UNII:
BN93L2NT5I
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOXAVERINE
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Ischemia
Unknown
MOXAVERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P3P08Y1XJ4
Molecule Type:
Small molecule
Molecular Formula:
C20H21NO2
Molecular Weight:
307.39
AlogP:
4.41
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
5.0
Source:
AZD0328
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
AZD0328
×
Maximum Phase:
2
First Approval:
None
UNII:
2B218X5QIY
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
ISTIRATUMAB
2
Antibody
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Pancreatic Neoplasms
Insulin-like growth factor I receptor inhibitor
ISTIRATUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
XLR461MD3M
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIBINETIDE
2
Protein
Investigational
Unknown
Unknown
Depressive Disorder
Unknown
CIBINETIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
9W5677JKDA
Molecule Type:
Protein
Molecular Formula:
C51H84N16O21
Molecular Weight:
1257.32
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ORTATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Glioblastoma; Kidney Neoplasms; Lung Neoplasms; Lymphoma
Unknown
ORTATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
8H61Y4E29N
Molecule Type:
Small molecule
Molecular Formula:
C44H57NO17
Molecular Weight:
871.93
AlogP:
3.66
PSA:
245.82
HBD:
3.0
HBA:
#RotB:
10.0
Source:
RELMAPIRAZIN
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Unknown
RELMAPIRAZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3UQB8PQ6H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N6O8
Molecular Weight:
372.29
AlogP:
-4.01
PSA:
251.08
HBD:
8.0
HBA:
#RotB:
8.0
Source:
NT-501
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NT-501
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALICATIB
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Osteoporosis
Cathepsin K inhibitor
BALICATIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E00MVC7O57
Molecule Type:
Small molecule
Molecular Formula:
C23H33N5O2
Molecular Weight:
411.55
AlogP:
2.29
PSA:
88.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LY-295501
2
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Unknown
LY-295501
×
Maximum Phase:
2
First Approval:
None
UNII:
240Y4YO0TN
Molecule Type:
Small molecule
Molecular Formula:
C15H12Cl2N2O4S
Molecular Weight:
387.24
AlogP:
3.44
PSA:
84.5
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PRILIXIMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
T-cell surface antigen CD4 negative modulator
PRILIXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATP
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ATP
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LETETRESGENE AUTOLEUCEL
2
Gene
Investigational
Unknown
Unknown
Neoplasms
Unknown
LETETRESGENE AUTOLEUCEL
×
Maximum Phase:
2
First Approval:
None
UNII:
B5ME4ZU4BS
Molecule Type:
Gene
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PALMIDROL
2
Small molecule
Investigational
Unknown
Unknown
Tourette Syndrome
Unknown
PALMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
6R8T1UDM3V
Molecule Type:
Small molecule
Molecular Formula:
C18H37NO2
Molecular Weight:
299.5
AlogP:
4.58
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
16.0
Source:
GOLOTIMOD
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Stomatitis
Unknown
GOLOTIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
637C487Y09
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O5
Molecular Weight:
333.34
AlogP:
0.47
PSA:
145.51
HBD:
5.0
HBA:
#RotB:
8.0
Source:
BI 44370 TA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 44370 TA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(+)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne; Prediabetic State; Friedreich Ataxia; Hypertension
Unknown
(+)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LD6B6TT8Q5
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CHOLESTEROL
2
Small molecule
Investigational
Unknown
Unknown
Asperger Syndrome; Autistic Disorder; Head and Neck Neoplasms; Porokeratosis; Smith-Lemli-Opitz Syndrome
Unknown
CHOLESTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
97C5T2UQ7J
Molecule Type:
Small molecule
Molecular Formula:
C27H46O
Molecular Weight:
386.66
AlogP:
7.39
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
CLA
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CLA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARRAGEENAN
2
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome; Conjunctivitis, Viral; Papillomavirus Infections
Unknown
CARRAGEENAN
×
Maximum Phase:
2
First Approval:
None
UNII:
5C69YCD2YJ
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIROMELATINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Sleep Initiation and Maintenance Disorders
Melatonin receptor agonist
PIROMELATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3UN2146K9
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O4
Molecular Weight:
312.33
AlogP:
2.1
PSA:
84.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SABARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Testicular Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SABARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XS499WOZ93
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO13
Molecular Weight:
643.64
AlogP:
-0.13
PSA:
235.53
HBD:
7.0
HBA:
#RotB:
6.0
Source:
L 756423
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
L 756423
×
Maximum Phase:
2
First Approval:
None
UNII:
862SGU1BRL
Molecule Type:
Small molecule
Molecular Formula:
C39H48N4O5
Molecular Weight:
652.84
AlogP:
4.22
PSA:
118.28
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DELEOBUVIR SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
DELEOBUVIR SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
6X4T3L6431
Molecule Type:
Small molecule
Molecular Formula:
C34H32BrN6NaO3
Molecular Weight:
675.56
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TOREFORANT
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Histamine H4 receptor antagonist
TOREFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
U6LA7G393X
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6
Molecular Weight:
392.55
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PILARALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Lymphoma; Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
PILARALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
60ES45KTMK
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN6O4S
Molecular Weight:
541.03
AlogP:
4.51
PSA:
148.33
HBD:
4.0
HBA:
#RotB:
8.0
Source:
IMO-8400
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IMO-8400
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENETHYL ISOTHIOCYANATE
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PHENETHYL ISOTHIOCYANATE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROLIPRAM
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Huntington Disease; Nervous System Diseases; Multiple Sclerosis
Unknown
ROLIPRAM
×
Maximum Phase:
2
First Approval:
None
UNII:
K676NL63N7
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO3
Molecular Weight:
275.35
AlogP:
2.62
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
176
177
178
179
180
181
182
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA